Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Craig A. Johnson Insider Profile
4 Followers
Craig A. Johnson, Director at Mirati Therapeutics, holds 0.00 shares in Mirati Therapeutics (Ticker: MRTX), holds 3.00K shares in Odonate (Ticker: ODTC), holds 12.00K shares in La Jolla Pharma (Ticker: LJPC).
Craig A. Johnson Mirati Therapeutics (MRTX)Director
Mirati Therapeutics (MRTX)
Director
Not Ranked
Craig A. Johnson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Craig A. Johnson holds in companies
Most Profitable Insider Trade
The most profitable trade made by Craig A. Johnson
Craig A. Johnson's Trading History
Mirati Therapeutics
Jan 23, 2024
―
Uninformative Sell
―
$0.00
Odonate
Dec 31, 2020
Director
Informative Buy
51.00K
$58.57M
La Jolla Pharma
―
―
―
$74.64K
Raptor Pharmaceutical Corp.
―
―
―
$292.32K
Pure Bioscience
―
CFO
―
$0.00
DMK Pharmaceuticals
Mar 07, 2013
Director
Uninformative Buy
―
$293.48
Heron Therapeutics
Jan 19, 2024
Director
Uninformative Buy
―
$69.77K
List of latest transactions for each holding click on a transaction to see Craig A. Johnson's performance on stock
You May Also Like
Craig A. Johnson insider profile FAQ
What is the percentage of profitable transactions made by Craig A. Johnson?
The percentage of profitable transactions made by Craig A. Johnson is ―.
What is the average return per transaction made by Craig A. Johnson?
The average return per transaction made by Craig A. Johnson is ―.
What stocks does Craig A. Johnson hold?
Craig A. Johnson holds: MRTX, ODTC, LJPC, RPTP, PURE, DMKPQ, HRTX stocks.
What was Craig A. Johnson’s latest transaction?
Craig A. Johnson latest transaction was an Uninformative Sell of ―.
What was Craig A. Johnson's most profitable transaction?
Craig A. Johnson’s most profitable transaction was an Informative Buy of ODTC stock on December 31, 2020. The return on the trade was -92.90%.
What is Craig A. Johnson's role in Mirati Therapeutics?
Craig A. Johnson's role in Mirati Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.